Insider Trading History of Enterprise Partners Management Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Enterprise Partners Management Llc since 2011. The trader's CIK number is 1504598. At the time of the last reporting, Enterprise Partners Management Llc was the 10% Owner of Eiger Biopharmaceuticals, Inc.. (stock ticker symbol EIGR). Also see all insider trading activities at Eiger Biopharmaceuticals, Inc..

Note that in the past Enterprise Partners Management LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (CLDN) by Enterprise Partners Management Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CLDN 133,083 $1,064,664 0 $0 0 $0

Yearly summary of insider trading at Complete Genomics Inc (GNOM) by Enterprise Partners Management Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 GNOM 100,000 $305,000 0 $0 0 $0


Insider trading activities at 2 companies by Enterprise Partners Management Llc:

1. Eiger Biopharmaceuticals, Inc. (CLDN)

2. Complete Genomics Inc (GNOM)

Table 1. Insider trading of Eiger Biopharmaceuticals, Inc. (CLDN) by Enterprise Partners Management Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-02-04 CLDN Buy 133,083 8.00 1,064,664

Table 2. Insider trading of Complete Genomics Inc (GNOM) by Enterprise Partners Management Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-12-14 GNOM Buy 100,000 3.05 305,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Enterprise Partners Management Llc (10% Owner of Eiger Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.